This topic contains a solution. Click here to go to the answer

Author Question: A nurse provides teaching to a patient who has had a hysterectomy and is about to begin hormone ... (Read 20 times)

maychende

  • Hero Member
  • *****
  • Posts: 556
A nurse provides teaching to a patient who has had a hysterectomy and is about to begin hormone therapy to manage menopausal symptoms. Which statement by the patient indicates understanding of the teaching?
 
  a. Because I am not at risk for uterine can-cer, I can take hormones indefinitely.
  b. I can take estrogen to reduce my risk of cardiovascular disease.
  c. I should take the lowest effective dose for the shortest time needed.
  d. I will need a progestin/estrogen combi-nation since I have had a hysterectomy.

Question 2

A patient is being treated for chemotherapy-induced nausea and vomiting (CINV) with ondansetron Zofran and dexamethasone.
 
  The patient reports getting relief during and imme-diately after chemotherapy but has significant nausea and vomiting several days after each che-motherapy treatment. What will the nurse do? a. Contact the provider to discuss increasing the dose of ondansetron.
  b. Suggest giving prolonged doses of dex-amethasone.
  c. Suggest adding aprepitant Emend to the medication regimen.
  d. Tell the patient to ask the provider about changing the ondansetron to aprepitant.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

missalyssa26

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

C
For patients who have undergone hysterectomy, progestin is unnecessary; estrogen-only prepara-tions still carry increased risk of breast cancer and should be taken in the lowest effective dose for the shortest time possible. Even though uterine cancer is no longer a possibility, breast cancer is still a risk. Studies have shown no protection against coronary heart disease but increased risk of stroke and breast cancer with estrogens.

Answer to Question 2

C
The current regimen of choice for patients taking highly emetogenic drugs consists of three agents: aprepitant plus dexamethasone plus a 5-HT3 antagonist, such as ondansetron. Aprepitant has a prolonged duration of action and can prevent delayed CINV as well as acute CINV. In-creasing the dose of ondansetron will not help treat the delayed CINV. Glucocorticoids should be given intermittently and for short periods to avoid side effects. Changing the ondansetron to aprepitant is not recommended.




maychende

  • Member
  • Posts: 556
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


xiaomengxian

  • Member
  • Posts: 311
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

For a complete list of videos, visit our video library